Concepedia

Yukinori Take

YT

14

Publications

617

Citations

13

H-Index

1986

Active since

Affiliations

Hiroshima University(Current)

RaQualia Pharma (Japan)

Meiji (Japan)

University of Maryland, Baltimore

Merck (Japan)

Yukinori Take is an author at Hiroshima University specializing in medicine, drug discovery, and molecular biology.

Top concepts

Publications per year

1986–2017

14

Publications

14

A prostaglandin E (PGE) receptor EP4 antagonist protects natural killer cells from PGE<sub>2</sub>-mediated immunosuppression and inhibits breast cancer metastasis

Xinrong Ma, Dawn Holt, Namita Kundu et al. · OncoImmunology · 2013 · 99 citations · Full text

Tegoprazan, a Novel Potassium-Competitive Acid Blocker to Control Gastric Acid Secretion and Motility

Nobuyuki Takahashi, Yukinori Take · Journal of Pharmacology and Experimental Therapeutics · 2017 · 98 citations · Full text

Comparative studies of the inhibitory properties of antibiotics on human immunodeficiency virus and avian myeloblastosis virus reverse transcriptases and cellular DNA polymerases.

Yukinori Take, Yoshio Inouye, SHOSHIRO NAKAMURA et al. · The Journal of Antibiotics · 1989 · 64 citations · Full text

Inhibition of proliferation of human immunodeficiency virus type 1 by novel heteropolyoxotungstates in vitro

Yukinori Take, Yoshiki Tokutake, Yoshio Inouye et al. · Antiviral Research · 1991 · 64 citations

, , +8

Prostaglandin E receptor EP4 is a therapeutic target in breast cancer cells with stem-like properties

Namita Kundu, Xinrong Ma, Tyler Kochel et al. · Breast Cancer Research and Treatment · 2013 · 62 citations · Full text

, , +17

Rows per page

1–5 of 14